Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Rehabilitation | 33 | 2026 | 71 | 12.850 |
Why?
|
| Heart Diseases | 10 | 2022 | 226 | 3.240 |
Why?
|
| Patient Compliance | 6 | 2026 | 365 | 2.640 |
Why?
|
| Hospitalization | 16 | 2023 | 1393 | 2.460 |
Why?
|
| Cardiovascular Diseases | 10 | 2025 | 866 | 2.460 |
Why?
|
| Smoking Cessation | 10 | 2019 | 558 | 2.160 |
Why?
|
| Exercise Test | 6 | 2023 | 257 | 2.080 |
Why?
|
| Cardiology | 8 | 2025 | 170 | 1.970 |
Why?
|
| Coronary Disease | 4 | 2023 | 248 | 1.810 |
Why?
|
| Exercise Therapy | 10 | 2025 | 104 | 1.630 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 496 | 1.570 |
Why?
|
| Inpatients | 8 | 2023 | 311 | 1.550 |
Why?
|
| Exercise | 9 | 2023 | 964 | 1.350 |
Why?
|
| Outpatients | 7 | 2019 | 142 | 1.340 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2021 | 274 | 1.330 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2017 | 187 | 1.330 |
Why?
|
| Patient Participation | 5 | 2023 | 231 | 1.280 |
Why?
|
| Coronary Artery Bypass | 5 | 2022 | 298 | 1.170 |
Why?
|
| Humans | 78 | 2026 | 65606 | 1.120 |
Why?
|
| Echocardiography | 2 | 2023 | 512 | 1.070 |
Why?
|
| Patient Readmission | 6 | 2023 | 446 | 1.070 |
Why?
|
| United States | 32 | 2026 | 8138 | 1.030 |
Why?
|
| Quality Improvement | 3 | 2018 | 470 | 1.010 |
Why?
|
| Aged | 35 | 2026 | 14966 | 0.970 |
Why?
|
| Middle Aged | 33 | 2026 | 18299 | 0.970 |
Why?
|
| Heart Valve Diseases | 2 | 2016 | 95 | 0.900 |
Why?
|
| Smoking | 3 | 2019 | 865 | 0.900 |
Why?
|
| Preventive Medicine | 3 | 2015 | 25 | 0.850 |
Why?
|
| Patient Dropouts | 2 | 2026 | 52 | 0.840 |
Why?
|
| Smokers | 3 | 2019 | 117 | 0.810 |
Why?
|
| Female | 41 | 2026 | 34166 | 0.810 |
Why?
|
| Male | 38 | 2026 | 31112 | 0.790 |
Why?
|
| Nicotine | 2 | 2018 | 118 | 0.790 |
Why?
|
| Cigarette Smoking | 1 | 2023 | 58 | 0.780 |
Why?
|
| Retrospective Studies | 22 | 2023 | 6904 | 0.780 |
Why?
|
| Fear | 1 | 2023 | 71 | 0.770 |
Why?
|
| Quality Indicators, Health Care | 4 | 2018 | 345 | 0.770 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 704 | 0.740 |
Why?
|
| Self Efficacy | 1 | 2023 | 203 | 0.740 |
Why?
|
| Internship and Residency | 3 | 2024 | 819 | 0.730 |
Why?
|
| Fractional Flow Reserve, Myocardial | 1 | 2022 | 21 | 0.720 |
Why?
|
| Coronary Artery Disease | 3 | 2014 | 326 | 0.710 |
Why?
|
| Coronary Stenosis | 1 | 2022 | 41 | 0.710 |
Why?
|
| Accidental Falls | 1 | 2022 | 129 | 0.700 |
Why?
|
| Ambulatory Care | 2 | 2014 | 320 | 0.700 |
Why?
|
| Weight Loss | 2 | 2014 | 279 | 0.690 |
Why?
|
| Fellowships and Scholarships | 2 | 2012 | 107 | 0.680 |
Why?
|
| Surveys and Questionnaires | 6 | 2023 | 2794 | 0.670 |
Why?
|
| Binge Drinking | 1 | 2021 | 38 | 0.660 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2022 | 226 | 0.650 |
Why?
|
| Electrocardiography | 1 | 2023 | 558 | 0.650 |
Why?
|
| Cost Sharing | 1 | 2019 | 15 | 0.630 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2020 | 69 | 0.620 |
Why?
|
| Walking | 2 | 2023 | 241 | 0.610 |
Why?
|
| Motivation | 2 | 2019 | 295 | 0.590 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 484 | 0.590 |
Why?
|
| Tobacco Use Disorder | 2 | 2019 | 245 | 0.580 |
Why?
|
| Heart Failure | 7 | 2023 | 943 | 0.560 |
Why?
|
| Cardiology Service, Hospital | 1 | 2018 | 17 | 0.560 |
Why?
|
| Alcoholism | 1 | 2021 | 328 | 0.550 |
Why?
|
| Health Services Accessibility | 3 | 2024 | 595 | 0.540 |
Why?
|
| Myocardial Infarction | 3 | 2020 | 924 | 0.540 |
Why?
|
| Obesity | 3 | 2014 | 1266 | 0.520 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2016 | 7 | 0.500 |
Why?
|
| Lung Diseases | 1 | 2018 | 183 | 0.500 |
Why?
|
| Atrial Fibrillation | 3 | 2020 | 872 | 0.480 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 715 | 0.480 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 2517 | 0.470 |
Why?
|
| Postoperative Complications | 3 | 2019 | 1331 | 0.460 |
Why?
|
| Patient Transfer | 1 | 2016 | 92 | 0.460 |
Why?
|
| Decision Making | 1 | 2019 | 420 | 0.460 |
Why?
|
| Mitral Valve | 1 | 2016 | 130 | 0.440 |
Why?
|
| Referral and Consultation | 4 | 2022 | 435 | 0.440 |
Why?
|
| Heart Rate | 3 | 2023 | 331 | 0.430 |
Why?
|
| Employment | 1 | 2015 | 131 | 0.430 |
Why?
|
| Postoperative Care | 1 | 2014 | 124 | 0.420 |
Why?
|
| Telemedicine | 1 | 2019 | 360 | 0.420 |
Why?
|
| Aortic Valve | 1 | 2016 | 192 | 0.420 |
Why?
|
| Health Care Surveys | 1 | 2015 | 293 | 0.420 |
Why?
|
| Pilot Projects | 3 | 2023 | 1025 | 0.420 |
Why?
|
| Patient Discharge | 3 | 2020 | 523 | 0.410 |
Why?
|
| Exercise Tolerance | 3 | 2025 | 84 | 0.400 |
Why?
|
| Physical Therapy Modalities | 1 | 2013 | 46 | 0.390 |
Why?
|
| Medicare | 6 | 2024 | 617 | 0.380 |
Why?
|
| Appointments and Schedules | 1 | 2012 | 61 | 0.370 |
Why?
|
| Prescriptions | 2 | 2022 | 33 | 0.360 |
Why?
|
| Aged, 80 and over | 12 | 2021 | 5622 | 0.360 |
Why?
|
| Guidelines as Topic | 1 | 2012 | 162 | 0.340 |
Why?
|
| American Heart Association | 4 | 2025 | 130 | 0.330 |
Why?
|
| Risk Assessment | 5 | 2021 | 2099 | 0.330 |
Why?
|
| Adipose Tissue | 1 | 2013 | 301 | 0.320 |
Why?
|
| Databases, Factual | 4 | 2018 | 877 | 0.310 |
Why?
|
| Nurses | 2 | 2021 | 108 | 0.290 |
Why?
|
| Time Factors | 6 | 2021 | 3783 | 0.290 |
Why?
|
| Nicotinic Agonists | 1 | 2008 | 39 | 0.280 |
Why?
|
| Acute Disease | 3 | 2019 | 681 | 0.280 |
Why?
|
| Incidence | 3 | 2022 | 1411 | 0.280 |
Why?
|
| Minnesota | 4 | 2016 | 42 | 0.280 |
Why?
|
| Counseling | 3 | 2021 | 378 | 0.280 |
Why?
|
| Survival Rate | 4 | 2019 | 863 | 0.270 |
Why?
|
| Curriculum | 1 | 2012 | 613 | 0.270 |
Why?
|
| Risk Factors | 8 | 2021 | 5439 | 0.270 |
Why?
|
| Smoking Prevention | 1 | 2008 | 163 | 0.260 |
Why?
|
| Single-Blind Method | 3 | 2023 | 144 | 0.260 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 1702 | 0.260 |
Why?
|
| Length of Stay | 4 | 2019 | 832 | 0.250 |
Why?
|
| Hospital Mortality | 4 | 2019 | 879 | 0.240 |
Why?
|
| Social Class | 2 | 2023 | 139 | 0.230 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 1116 | 0.210 |
Why?
|
| Treatment Outcome | 7 | 2019 | 5829 | 0.210 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 403 | 0.210 |
Why?
|
| Prognosis | 4 | 2016 | 1794 | 0.210 |
Why?
|
| Certification | 1 | 2024 | 58 | 0.200 |
Why?
|
| Massachusetts | 2 | 2019 | 2148 | 0.200 |
Why?
|
| Logistic Models | 2 | 2021 | 1282 | 0.190 |
Why?
|
| Habits | 1 | 2022 | 21 | 0.190 |
Why?
|
| Physical Exertion | 1 | 2022 | 81 | 0.180 |
Why?
|
| Registries | 1 | 2026 | 905 | 0.180 |
Why?
|
| Heart Transplantation | 1 | 2023 | 179 | 0.180 |
Why?
|
| Attitude | 1 | 2022 | 101 | 0.170 |
Why?
|
| Depression | 2 | 2018 | 914 | 0.170 |
Why?
|
| Oxygen Consumption | 1 | 2022 | 213 | 0.170 |
Why?
|
| Alcohol-Related Disorders | 1 | 2021 | 37 | 0.170 |
Why?
|
| Yoga | 1 | 2020 | 15 | 0.160 |
Why?
|
| Health Status | 1 | 2022 | 451 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2022 | 322 | 0.150 |
Why?
|
| Amiodarone | 1 | 2019 | 22 | 0.150 |
Why?
|
| Cross-Sectional Studies | 3 | 2022 | 2703 | 0.150 |
Why?
|
| Potassium | 1 | 2019 | 103 | 0.150 |
Why?
|
| Hospitals | 2 | 2023 | 391 | 0.150 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 742 | 0.150 |
Why?
|
| Atrial Flutter | 1 | 2019 | 33 | 0.150 |
Why?
|
| Telephone | 1 | 2019 | 123 | 0.150 |
Why?
|
| Postoperative Period | 2 | 2016 | 135 | 0.150 |
Why?
|
| Income | 1 | 2019 | 175 | 0.140 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2019 | 103 | 0.140 |
Why?
|
| Wound Healing | 1 | 2019 | 195 | 0.140 |
Why?
|
| Surgical Procedures, Operative | 1 | 2019 | 144 | 0.140 |
Why?
|
| Intention | 1 | 2018 | 72 | 0.140 |
Why?
|
| Life Style | 1 | 2020 | 320 | 0.140 |
Why?
|
| Double-Blind Method | 1 | 2019 | 749 | 0.130 |
Why?
|
| Dyspnea | 1 | 2018 | 124 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2019 | 585 | 0.130 |
Why?
|
| Pandemics | 1 | 2022 | 679 | 0.130 |
Why?
|
| Secondary Prevention | 3 | 2025 | 164 | 0.130 |
Why?
|
| Plethysmography | 2 | 2014 | 12 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 294 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2019 | 441 | 0.120 |
Why?
|
| Emergencies | 1 | 2016 | 123 | 0.120 |
Why?
|
| Myocardial Revascularization | 1 | 2016 | 78 | 0.120 |
Why?
|
| Erythrocyte Transfusion | 1 | 2016 | 78 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2018 | 526 | 0.120 |
Why?
|
| Mass Screening | 1 | 2021 | 706 | 0.120 |
Why?
|
| Return to Work | 1 | 2015 | 26 | 0.120 |
Why?
|
| Physicians | 1 | 2021 | 489 | 0.120 |
Why?
|
| Anxiety | 1 | 2018 | 436 | 0.110 |
Why?
|
| Program Evaluation | 1 | 2017 | 497 | 0.110 |
Why?
|
| Skinfold Thickness | 1 | 2014 | 16 | 0.110 |
Why?
|
| Adult | 7 | 2024 | 17448 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 205 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 772 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 193 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 79 | 0.110 |
Why?
|
| Advisory Committees | 1 | 2015 | 113 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 112 | 0.110 |
Why?
|
| Insurance Coverage | 1 | 2014 | 99 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2018 | 484 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 232 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2015 | 889 | 0.100 |
Why?
|
| Insurance, Health | 1 | 2014 | 152 | 0.100 |
Why?
|
| Global Health | 1 | 2014 | 186 | 0.100 |
Why?
|
| Societies, Medical | 3 | 2025 | 402 | 0.100 |
Why?
|
| Propensity Score | 3 | 2020 | 183 | 0.100 |
Why?
|
| Comorbidity | 1 | 2016 | 1123 | 0.100 |
Why?
|
| Waist Circumference | 1 | 2013 | 47 | 0.100 |
Why?
|
| Body Height | 1 | 2013 | 66 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 427 | 0.090 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 354 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2013 | 233 | 0.090 |
Why?
|
| Body Weight | 1 | 2013 | 380 | 0.090 |
Why?
|
| Young Adult | 3 | 2016 | 4850 | 0.090 |
Why?
|
| Adolescent | 3 | 2016 | 6400 | 0.080 |
Why?
|
| Data Collection | 1 | 2012 | 385 | 0.080 |
Why?
|
| Recovery of Function | 2 | 2025 | 290 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2021 | 2640 | 0.080 |
Why?
|
| Physician's Role | 1 | 2011 | 125 | 0.080 |
Why?
|
| Chewing Gum | 1 | 2008 | 9 | 0.070 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2007 | 82 | 0.060 |
Why?
|
| Aspirin | 1 | 2007 | 172 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2007 | 235 | 0.060 |
Why?
|
| Benzimidazoles | 1 | 2004 | 57 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 799 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2023 | 57 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 153 | 0.050 |
Why?
|
| Patient Outcome Assessment | 1 | 2023 | 57 | 0.050 |
Why?
|
| Metabolic Equivalent | 1 | 2022 | 13 | 0.050 |
Why?
|
| Patients | 1 | 2022 | 113 | 0.040 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 467 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2004 | 332 | 0.040 |
Why?
|
| Symptom Flare Up | 1 | 2020 | 16 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2020 | 70 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 67 | 0.040 |
Why?
|
| Caregivers | 1 | 2023 | 291 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 855 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 500 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 183 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 134 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2020 | 591 | 0.040 |
Why?
|
| Data Warehousing | 1 | 2018 | 7 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 822 | 0.030 |
Why?
|
| Consensus | 1 | 2018 | 186 | 0.030 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2016 | 11 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 151 | 0.030 |
Why?
|
| Data Mining | 1 | 2016 | 39 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 294 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 747 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 311 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1215 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 215 | 0.030 |
Why?
|
| Medical Records | 1 | 2014 | 140 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1470 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 121 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2016 | 384 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2014 | 210 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2014 | 764 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 660 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2011 | 7 | 0.020 |
Why?
|
| Wisconsin | 1 | 2011 | 17 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2011 | 41 | 0.020 |
Why?
|
| Medical Audit | 1 | 2011 | 66 | 0.020 |
Why?
|
| Disease Management | 1 | 2011 | 237 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 260 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 2004 | 36 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2004 | 96 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 421 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 1649 | 0.010 |
Why?
|
| Mice | 1 | 2004 | 11199 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 21512 | 0.000 |
Why?
|